Please login to the form below

David Chantry appointed as Head of Quality & Compliance (UK and Ireland) for Ashfield Commercial and Clinical

David has been successful in a number of roles across various healthcare environments prior to joining the company, and has taken over this important leadership role to spearhead the development and implementation of the quality and compliance initiatives as they relate to the business and regulatory requirements in the UK and Ireland.

David, who will be responsible for delivery of quality and compliance initiatives as well as inputting to overall strategy and development, commented: “I’m delighted to be part of a great team and working in such a dynamic and pivotal part of the business. Ensuring that high standards of care and service delivery are maintained, and that Ashfield is compliant with our regulatory obligations is a vital area within the industry. This is crucial as our clients, patients and other stakeholders seek assurances that we can provide them with a safe and effective service, whilst continually seeking to improve what we do.

I’m looking forward to continuing our partnership with our current clients and to developing new business with future prospects. "Talking about how his experience in the sector will help shape this role, David said: “I started work in the healthcare sector over 25 years ago as a Nursing Assistant, before training and qualifying to diploma level as a Registered Nurse. 
My area of work and speciality was Critical Care. I then went on to complete a bachelor’s degree in Health Related Studies before leaving the National Health Service in 2002. Since then I have been lucky to experience many different roles, including sales, marketing and business development within the medical devices field. Since 2010, I have held a number of key roles at a Senior Nursing level which have focussed on quality, compliance and governance of clinical service delivery. Throughout my career, since qualifying as a nurse, I have maintained my nursing registration and will continue to do so.”

Discussing the future of the Ashfield Quality and Compliance Department, David explained: “We have a well-established and committed team within the department, whose focus is on developing and improving the standards and effectiveness of the services that we provide in order to improve the lives of our patients. We are also dedicated to supporting our colleagues and partnering with our clients to achieve exactly the same mission. Clients are always seeking to assure patients, healthcare providers and professionals that the services that they invest in and deliver are safe and effective, and that they are continually improving.

The Quality and Compliance Department will continue to support and evolve in accordance with regulatory, client and patient requirements, which means we are constantly evaluating the way we work, as a team and as an organisation.”

If you would like to understand more about Ashfield and what we do, please visit our website:

20th October 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.